ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants

Hu, Chao; Shen, Meiying; Han, Xiaojian; Chen, Qian; Li, Luo; Chen, Siyin; Zhang, Jing; Gao, Fengxia; Wang, Wang; Wang, Yingming; Li, Tingting; Li, Shenglong; Huang, Jingjing; Wang, Jianwei; Zhu, Ju; Chen, Dan; Wu, Qingchen; Tao, Kun; Pang, Da*; Jin, Aishun*哈尔滨医科大学; 1
Genes & Diseases2022-1DOI: 10.1016/j.gendis.2021.05.006
21被引4阅读
引用收藏
分享

摘要

Despite the growing knowledge of T cell responses in COVID-19 patients, there is a lack of detailed characterizations for T cell-antigen interactions and T cell functions. Here, with a predicted peptide library from SARS-CoV-2 S and N proteins, we found that specific CD8(+) T cell responses were identified in over 75% of COVID-19 convalescent patients (15/20) and an epitope from the N protein, N361-369 (KTFPPTEPK), was the most dominant epitope from our selected peptide library. Importantly, we discovered 2 N361-369-specific T cell receptors (TCRs) with high functional avidity that were independent of the CD8 co-receptor. These TCRs exhibited complementary cross-reactivity to several presently reported N361-369 mutant variants, as to the wild-type epitope. Further, the natural functions of these TCRs in the cytotoxic immunity against SARS-CoV-2 were determined with dendritic cells (DCs) and the lung organoid model. We found that the N361-369 epitope could be normally processed and endogenously presented by these different types of antigen presenting cells, to elicit successful activation and effective cytotoxicity of CD8(+) T cells ex vivo. Our study evidenced potential mechanisms of cellular immunity to SARS-CoV-2, and illuminated potential ways of viral clearance in COVID-19 patients. These results indicate that utilizing CD8-independent TCRs against SARS-CoV-2-associated antigens may provide functional superiority that is beneficial for the adoptive cell immunotherapies based on natural or genetically engineered T cells. Additionally, this information is highly relevant for the development of the next-generation vaccines with protections against continuously emerged SARS-CoV-2 mutant strains.

学科与关键词

关键词
CD8(+)T cellHLA class ILung organoidSARS-CoV-2T cell epitopeTCR
相关
加载中…
  • Specific CD8+ TCR Repertoire Recognizing Conserved Antigens of SARS-CoV-2 in Unexposed Population: A Prerequisite for Broad-Spectrum CD8+ T Cell Immunity
    Hu, Wei; He, Meifang; Wang, Xiaoning; Sun, Qiang; Kuang, Ming*Vaccines, 2021, 9(10): 1093.被引 4
  • CD8+ T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2
    Qiu, Congling; Xiao, Chanchan; Wang, Zhigang; Zhu, Guodong; Mao, Lipeng; Chen, Xiongfei; Gao, Lijuan; Deng, Jieping; Su, Jun; Su, Huanxing; Fang, Evandro Fei; Zhang, Zhang-Jin; Zhang, Jikai; Xie, Caojun; Yuan, Jun; Luo, Oscar Junhong; Huang, Lian; Wang, Pengcheng*; Chen, Guobing*Frontiers in Immunology, 2022, 12: 764949.被引 11
  • SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response
    Xiao, Chanchan; Mao, Lipeng; Wang, Zhigang; Gao, Lijuan; Zhu, Guodong; Su, Jun; Chen, Xiongfei; Yuan, Jun; Hu, Yutian; Yin, Zhinan; Xie, Jun; Ji, Weiqing; Niu, Haitao; Gao, Feng; Luo, Oscar Junhong; Xiao, Lianbo*; Wang, Pengcheng*; Chen, Guobing*iScience, 2022, 25(3): 103934.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Genes & Diseases
发表日期
2022-01
卷期
第 9 卷, 第 1 期
页码
216-229
DOI
10.1016/j.gendis.2021.05.006
成果收录
SCIE
资助标注
Emergency Project from Chongqing Medical University; Chongqing Medical Uni-versity fund, China [X4457]

作者

  • H

    Hu, Chao (第一作者)

    chongqing med univ · 1

  • S

    Shen, Meiying

    harbin med univ

查看全部 20 位作者收起作者
  • H

    Han, Xiaojian

    1 · chongqing med univ

  • C

    Chen, Qian

    1 · chongqing med univ

  • L

    Li, Luo

    1 · chongqing med univ

  • C

    Chen, Siyin

    chongqing med univ · 1

  • Z

    Zhang, Jing

    chongqing med univ · 1

  • G

    Gao, Fengxia

    1 · chongqing med univ

  • W

    Wang, Wang

    chongqing med univ · 1

  • W

    Wang, Yingming

    chongqing med univ · 1

  • L

    Li, Tingting

    chongqing med univ · 1

  • L

    Li, Shenglong

    chongqing med univ · 1

  • H

    Huang, Jingjing

    chongqing med univ · 1

  • W

    Wang, Jianwei

    chongqing med univ · 1

  • Z

    Zhu, Ju

    1 · chongqing med univ

  • C

    Chen, Dan

    1 · chongqing med univ

  • W

    Wu, Qingchen

    1 · chongqing med univ

  • T

    Tao, Kun

    1 · chongqing med univ

  • P

    Pang, Da (通讯)

    harbin med univ

  • J

    Jin, Aishun (通讯)

    chongqing med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417